An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes.

Peter HanlonBhautesh D JaniElaine W ButterlyBarbara NichollJames LewseyDavid A McAllisterFrances S Mair

Published in: Communications medicine (2021)

Assessment of frailty/multimorbidity should be embedded within routine management of middle-aged and older people with T2D. Method of identification as well as features such as age impact baseline risk and should influence clinical decisions (e.g. glycaemic control).

Keyphrases

community dwelling
type diabetes
clinical practice
cross sectional
bioinformatics analysis